Uncomplicated Urinary Tract Infection
📧 Sign up to get email alerts when something new happens for Uncomplicated Urinary Tract Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-03-25FDA Approved: FOSFOMYCIN TROMETHAMINE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved Amneal's original application for fosfomycin tromethamine (fosfomycin trometamol), a generic antibiotic. It is indicated for tr…
-
FDA approval · 2023-12-11FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Original Application (Devatis, Inc.)
FDA approved an Original Application for amoxicillin and clavulanate potassium (amoxicillin/clavulanate) as a generic antibiotic formulation…
-
FDA approval · 2021-10-21FDA Approved: FOSFOMYCIN TROMETHAMINE — Original Application (Kesin Pharma Corporation)
The FDA approved Kesin Pharma Corporation's original ANDA for fosfomycin tromethamine, authorizing the marketing of a generic antibiotic.
-
FDA approval · 2020-04-22FDA Approved: LEVOFLOXACIN — Original Application (Gland Pharma Limited)
FDA approved an original application for levofloxacin from Gland Pharma Limited, authorizing a generic version of the antibiotic.
-
FDA approval · 2013-11-22FDA Approved: CEFIXIME — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for cefixime. This action updates the cefixime NDA, potentially expanding i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-11-14FDA Approved: NITROFURANTOIN (MACROCRYSTALS) — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for nitrofurantoin macrocrystals from Aurobindo Pharma Limited, authorizing a generic version of the…
-
FDA approval · 2009-03-05FDA Approved: NITROFURANTOIN MONOHYDRATE/ MACROCRYSTALLINE — Supplemental Application (Alvogen Inc.)
FDA approved a supplemental application for nitrofurantoin monohydrate/macrocyrstalline (Alvogen).
-
FDA approval · 2007-08-13FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Original Application (Sandoz Inc)
FDA approved Sandoz Inc's amoxicillin/clavulanate potassium as an Original Application (ANDA), granting approval for a generic antibiotic pr…